208 related articles for article (PubMed ID: 19696200)
1. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
[TBL] [Abstract][Full Text] [Related]
3. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
4. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.
Danjou F; Anni F; Perseu L; Satta S; Dessì C; Lai ME; Fortina P; Devoto M; Galanello R
Haematologica; 2012 Jul; 97(7):989-93. PubMed ID: 22271886
[TBL] [Abstract][Full Text] [Related]
6. Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.
Badens C; Joly P; Agouti I; Thuret I; Gonnet K; Fattoum S; Francina A; Simeoni MC; Loundou A; Pissard S
Haematologica; 2011 Nov; 96(11):1712-4. PubMed ID: 21791466
[TBL] [Abstract][Full Text] [Related]
7. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
[TBL] [Abstract][Full Text] [Related]
8. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
9. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
[TBL] [Abstract][Full Text] [Related]
12. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
14. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.
Jiang Z; Luo HY; Huang S; Farrell JJ; Davis L; Théberge R; Benson KA; Riolueang S; Viprakasit V; Al-Allawi NA; Ünal S; Gümrük F; Akar N; Başak AN; Osorio L; Badens C; Pissard S; Joly P; Campbell AD; Gallagher PG; Steinberg MH; Forget BG; Chui DH
Br J Haematol; 2016 Mar; 172(6):958-65. PubMed ID: 26771086
[TBL] [Abstract][Full Text] [Related]
15. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
[TBL] [Abstract][Full Text] [Related]
16. Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.
Banan M; Bayat H; Namdar-Aligoodarzi P; Azarkeivan A; Kamali K; Daneshmand P; Zaker-Kandjani B; Najmabadi H
Hemoglobin; 2013; 37(5):413-22. PubMed ID: 23805990
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
[No Abstract] [Full Text] [Related]
18. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
[TBL] [Abstract][Full Text] [Related]
19. Influences of genetic variation on fetal hemoglobin.
He Y; Lin W; Luo J
Pediatr Hematol Oncol; 2011 Nov; 28(8):708-17. PubMed ID: 22023465
[TBL] [Abstract][Full Text] [Related]
20. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
